4-methyl-2-(pyridin-3-yl)-1,3-thiazole-5-carboxamide
Structure Info
- Chemspace ID
- CSSB00009994110 (In-Stock Building Blocks)
- CAS
- 39091-14-0
- MFCD
- MFCD00171758, MFCD00171758
- IUPAC Name
- 4-methyl-2-(pyridin-3-yl)-1,3-thiazole-5-carboxamide
- Mol formula
- C10H9N3OS
- Mol weight
- 219 Da
- Catalog Number(s)
- 1G-409S, AA01X8L7, AG01X8NZ, BBLS00009994110, BBV-45113063, BD00861913, BG30295, CSC009994110, EN300-9540834, F1967-1627, FCH1689107, ST01XA4R, TX01X9TN, Y3409189, Z3235012535, bbls00009994110
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 0.55
- Heavy atoms count
- 15
- Rotatable bond count
- 2
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 0.1
- Polar surface area (Å)
- 69
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 1
- Zoom the structure
- CSSB00009994110
Items Overall 9 items from 2 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| 1st Scientific EU | 14 days | Germany To: | 90 | 100 mg | 709.50 | |
Description: 4-methyl-2-(3-pyridinyl)-1,3-thiazole-5-carboxamide; CAS: 39091-14-0 | ||||||
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 455.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 477.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 498.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 519.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 541.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 1,063.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 1,572.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 2,331.00 | |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire




![Chemical structure of 2-{2-fluoro-6-[4-(hydroxymethyl)piperidin-1-yl]pyridin-3-yl}-5-(pyridin-3-yl)-4H,5H,6H,7H-[1,3]thiazolo[5,4-c]pyridin-4-one - CSSB20465147262](/st/structure/200/9bc4ab961cbfed19d29772c91a56cfb6/OCC1CCN%2528CC1%2529C1%253DCC%253DC%2528C2%253DNC3%253DC%2528S2%2529C%2528%253DO%2529N%2528CC3%2529C2%253DCC%253DCN%253DC2%2529C%2528F%2529%253DN1.png)
![Chemical structure of 4-methyl-N-(2-{3-[(morpholin-4-yl)methyl]imidazo[2,1-b][1,3]thiazol-6-yl}phenyl)-2-(pyridin-3-yl)-1,3-thiazole-5-carboxamide - CSSB00102419764](/st/structure/200/9ee5e840e92d7a239da8b744ec012b5d/CC1%253DC%2528SC%2528%253DN1%2529C1%253DCC%253DCN%253DC1%2529C%2528%253DO%2529NC1%253DCC%253DCC%253DC1C1%253DCN2C%2528CN3CCOCC3%2529%253DCSC2%253DN1.png)
![Chemical structure of 1-[4-methyl-2-(pyridin-3-yl)-1,3-thiazol-5-yl]ethan-1-one - CSSB00000168838](/st/structure/200/0064db57707d671909bb1eaad3968b76/CC%2528%253DO%2529C1%253DC%2528C%2529N%253DC%2528S1%2529C1%253DCC%253DCN%253DC1.png)
![Chemical structure of 1-[4-methyl-2-(pyridin-3-yl)-1,3-thiazol-5-yl]ethan-1-one hydrochloride - CSSB00000747866](/st/structure/200/8190aa0b3ef3ee62a69ba77e6b94a2d2/Cl.CC%2528%253DO%2529C1%253DC%2528C%2529N%253DC%2528S1%2529C1%253DCC%253DCN%253DC1.png)




